# NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing

> **NCT01969370** · NA · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 645 (actual)

## Conditions studied

- Cancer
- Cardiovascular Disease
- Neurologic Dysfunction
- Congenital Abnormalities
- Hearing Loss

## Interventions

- **BEHAVIORAL:** Experimental

## Key facts

- **NCT ID:** NCT01969370
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-03-01
- **Target enrollment:** 645 (ACTUAL)
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01969370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01969370, "NCGENES: North Carolina Clinical Genomic Evaluation by NextGen Exome Sequencing". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01969370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*